CD40 anticorps (FITC)
Aperçu rapide pour CD40 anticorps (FITC) (ABIN7456735)
Antigène
Voir toutes CD40 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Isotype
- IgG2a, kappa
-
-
-
-
Indications d'application
- The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
-
Commentaires
-
Matching Isotype Control: FITC Mouse IgG2a, κ Isotype Control (ABIN7469777)
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.05 % Proclin300, 1 % BSA
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2~8°C and protected from prolonged exposure to light. Do not freeze.
-
-
- CD40
-
Autre désignation
- CD40
-
Sujet
- Tumor necrosis factor receptor superfamily member 5,Cd40,B-cell surface antigen CD40,Bp50,CD40L receptor,CD40,Tnfrsf5,CD40 is a 48 kD type I glycoprotein also known as BP50. It is a member of the TNFR superfamily primarily expressed on B cells, macrophages, follicular dendritic cells, endothelial cells, fibroblasts, and at low levels on plasma cells. CD40 has been reported to be involved in B cell differentiation, costimulation, isotype class-switching, and protection of B cells from apoptosis. Additionally, CD40 is important for T cell-B cell interactions. The ligand of CD40 is CD154 (CD40 ligand). The 5C3 antibody has been reported to promote B cell proliferation in the presence of anti-IgM, IL-4 or PMA, partially blocking CD40 binding to CD40L, and B cells rescue from apoptosis.
-
ID gène
- 958
-
UniProt
- P25942
-
Pathways
- Signalisation NF-kappaB, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Antigène
-